Novavax (NVAX)
Builds protein vaccines and Matrix-M partnerships around Nuvaxovid and R21/Matrix-M.
$10.79
vs last close+0.38 (+3.60%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.37
Revenue estimate
$72.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.51$2.93$0.62−$1.25$0.11−$0.06−$0.32Pending
Estimate−$0.75$0.71−$0.07−$1.08−$0.66−$0.25−$0.38−$0.37
Surprise+32.0%+312.7%+985.7%−15.7%+116.7%+76.0%+15.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$88.3M$666.7M$239.2M$70.4M$147.1M$139.5M$56.7MPending
Estimate$84.4M$343.9M$152.6M$42.1M$89.8M$79.8M$52.5M$72.7M
Surprise+4.7%+93.9%+56.8%+67.2%+63.8%+74.8%+8.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.08 | — | — |
| Sep 2027 | $0.43 | — | — |
| Jun 2027 | −$0.22 | — | — |
| Mar 2027 | −$0.31 | — | — |
| Dec 2026 | −$0.10 | — | — |
| Nov 2026 | −$0.37 | — | — |
| Aug 2026 | −$0.38 | −$0.32 | +15.8% |
| May 2026 | −$0.25 | −$0.06 | +76.0% |
| Feb 2026 | −$0.66 | $0.11 | +116.7% |
| Nov 2025 | −$1.08 | −$1.25 | −15.7% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.08 | — | — | $120.1M | — | — | — |
| Sep 2027 | $0.43 | — | — | $257.1M | — | — | — |
| Jun 2027 | −$0.22 | — | — | $19.9M | — | — | — |
| Mar 2027 | −$0.31 | — | — | $13.5M | — | — | — |
| Dec 2026 | −$0.10 | — | — | $93.8M | — | — | — |
| Nov 5, 2026 | −$0.37 | — | — | $72.7M | — | — | — |
| Aug 6, 2026 | −$0.38 | −$0.32 | +15.8% | $52.5M | $56.7M | +8.0% | +0.5% |
| May 6, 2026 | −$0.25 | −$0.06 | +76.0% | $79.8M | $139.5M | +74.8% | +15.6% |
| Feb 26, 2026 | −$0.66 | $0.11 | +116.7% | $89.8M | $147.1M | +63.8% | +17.4% |
| Nov 6, 2025 | −$1.08 | −$1.25 | −15.7% | $42.1M | $70.4M | +67.2% | −1.3% |
| Aug 6, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 10, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 11, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 2, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 8, 2017 | |||||||
| Feb 27, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 4, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Aug 10, 2015 |